NL7003000A - - Google Patents

Info

Publication number
NL7003000A
NL7003000A NL7003000A NL7003000A NL7003000A NL 7003000 A NL7003000 A NL 7003000A NL 7003000 A NL7003000 A NL 7003000A NL 7003000 A NL7003000 A NL 7003000A NL 7003000 A NL7003000 A NL 7003000A
Authority
NL
Netherlands
Application number
NL7003000A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7003000A publication Critical patent/NL7003000A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/80Cytochromes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989Microcapsule with solid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
NL7003000A 1969-03-05 1970-03-03 NL7003000A (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1626669 1969-03-05

Publications (1)

Publication Number Publication Date
NL7003000A true NL7003000A (it) 1970-09-08

Family

ID=11911735

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7003000A NL7003000A (it) 1969-03-05 1970-03-03

Country Status (7)

Country Link
US (1) US3642978A (it)
BR (1) BR7017141D0 (it)
ES (1) ES377132A1 (it)
FR (1) FR2060317B1 (it)
GB (1) GB1238811A (it)
NL (1) NL7003000A (it)
SE (1) SE370624B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072667A (en) * 1971-12-22 1978-02-07 Hitachi, Ltd. Process for recovering microbial cellular proteins
JPS5816471B2 (ja) * 1977-11-29 1983-03-31 持田製薬株式会社 免疫化学的測定試薬の安定化剤
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
IE914007A1 (en) * 1990-11-19 1992-05-20 Univ Illinois A protein being genetically engineered to provide¹orientability and a substrate having an oriented layer of¹proteins
EP1301786B1 (en) * 2000-07-21 2005-11-30 Evotec AG Method for the detection of apoptosis by determining cytochrome c as apoptosis-specific marker released into an extracellular medium through cellular release mechanisms
WO2006088832A2 (en) * 2005-02-14 2006-08-24 The Children's Hospital Of Philadelphia Methods for the treatment of sepsis and sepsis-associated cardiac dysfunction
CN110507815B (zh) * 2019-09-30 2023-02-14 成都通德药业有限公司 注射用细胞色素c及其制备方法

Also Published As

Publication number Publication date
BR7017141D0 (pt) 1973-02-13
US3642978A (en) 1972-02-15
ES377132A1 (es) 1972-05-16
FR2060317A1 (it) 1971-06-18
SE370624B (it) 1974-10-28
FR2060317B1 (it) 1974-02-22
DE2010191A1 (de) 1970-09-10
GB1238811A (it) 1971-07-14

Similar Documents

Publication Publication Date Title
AU429630B2 (it)
FR2060317B1 (it)
AU470301B1 (it)
AU427401B2 (it)
AU438128B2 (it)
AU470661B1 (it)
AU425297B2 (it)
AU428131B2 (it)
AU428074B2 (it)
AU417208B2 (it)
AU442285B2 (it)
AU428129B2 (it)
AU442322B2 (it)
CS151206B1 (it)
CS148793B1 (it)
AU4923469A (it)
AU5133369A (it)
AU5079269A (it)
AU436893A (it)
AU5066368A (it)
BE756388A (it)
BE755309A (it)
BE753873A (it)
BE753475A (it)
BE743847A (it)